Our therapies include, among others, the globally recognised brands Nourkrin®, Nourella® and Zymbilan®, which are preferred by dermatologists, trichologists, and health care professionals as monotherapies and in combination with other products as add-on and adjunctive therapies.
Our therapies are developed through research into the role that proteoglycans, a glycoprotein vital for the structural and functional integrity of various tissues, play in the pathology of a wide range of dermatological disorders.
Our patented production process enables us to produce proprietary delivery technologies that optimise absorption and digestion to maximise bioavailability and efficacy.
Because our therapies are biologically active, they can be used on a long-term basis, and they address not only symptoms but help to restore biological balance and normal biological function.